Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial-Reference-Cited by-同舟云学术

Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial

Published:2016-09 Issue:9 Volume:17 Page:1317-1324
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Rini Brian I,Dorff Tanya B,Elson Paul,Rodriguez Cristina Suarez,Shepard Dale,Wood Laura,Humbert Jordi,Pyle Linda,Wong Yu-Ning,Finke James H,Rayman Patricia A,Larkin James M G,Garcia Jorge A,Plimack Elizabeth R

Publisher

Elsevier BV

Subject

Oncology

Reference23 articles.

1. Pazopanib versus sunitinib in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2013

2. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

3. Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206;Rini;J Clin Oncol,2010

4. Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial;Rini;Lancet,2011

5. Local treatments for metastases of renal cell carcinoma: a systematic review;Dabestani;Lancet Oncol,2014

Cited by 217 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focal therapy for oligometastatic and oligoprogressive renal cell carcinoma: a narrative review;Future Oncology;2024-09-11

2. The treatment of metastatic renal cell carcinoma;Deutsches Ärzteblatt international;2024-08-23

3. Contemporary Management of Renal Cell Carcinoma: A Review for General Practitioners in Oncology;Current Oncology;2024-08-22

4. Renal cell carcinoma;The Lancet;2024-08

5. Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Annals of Oncology;2024-08